[Research on olaquindox induced endoplasmic reticulum stress related apoptosis on nephrotoxicity]

Abstract

Insights

Olaquindox induces renal tubular epithelial cell apoptosis and toxicity. This occurs through endoplasmic reticulum stress, involving increased reactive oxygen species and specific protein levels.

Area of Science:

  • Toxicology
  • Cell Biology
  • Biochemistry

Background:

  • Renal tubular epithelial cells are crucial for kidney function.
  • Olaquindox is an antimicrobial agent with potential toxic effects.
  • Endoplasmic reticulum stress is implicated in various cellular dysfunctions.

Purpose of the Study:

  • To investigate olaquindox-induced apoptosis in renal tubular epithelial cells.
  • To explore the role of endoplasmic reticulum stress in olaquindox toxicity.
  • To analyze the involvement of reactive oxygen species (ROS) and specific proteins in this pathway.

Main Methods:

  • Cell proliferation assessed by MTT assay to determine olaquindox concentrations.
  • Apoptotic cell morphology visualized using Hoechst-33258 staining.
  • Apoptosis rate and intracellular ROS measured by flow cytometry.
  • Western blot analysis for endoplasmic reticulum stress markers (GRP78, GRP94, CHOP).

Main Results:

  • Olaquindox exposure increased apoptosis rate and ROS levels in a dose-dependent manner.
  • Elevated levels of endoplasmic reticulum stress proteins (GRP78, GRP94, CHOP) were observed with increasing olaquindox concentration and exposure time.
  • Significant increases in ROS and CHOP were noted at 2 μmol/ml olaquindox and above.

Conclusions:

  • Olaquindox induces apoptosis and renal toxicity in renal tubular epithelial cells.
  • Endoplasmic reticulum stress-mediated pathways are likely involved in olaquindox-induced renal toxicity.
  • The study highlights a potential mechanism for olaquindox nephrotoxicity.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
593
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.0K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
507
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
179
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K